Results

Our company has validated results to be the leader in development of the next generation of novel cancer immunotherapies with our global team of scientific and commercial immunotherapy, immunonology, and oncology experts ​

Taking Immunotherapy to the Next Level

​Discovery

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity

ImmunOs Therapeutics AG is leading the next generation of immunotherapies by fast-tracking new discoveries to enhance combination therapies with novel human immunomodulatory proteins that have a role in both the innate and adaptive immune system for cancer treatment

Pipeline

A growing pipeline of novel drug candidates to antagonize multiple types of cancer tumors using the innate and adaptive immune system

People

Our mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease​